ICU Medical (ICUI)
(Delayed Data from NSDQ)
$175.04 USD
-1.70 (-0.96%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $175.02 -0.02 (-0.01%) 7:04 PM ET
2-Buy of 5 2
B Value C Growth B Momentum B VGM
ICU Medical (ICUI) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$161.00 | $190.00 | $146.00 | -8.91% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for ICU Medical comes to $161.00. The forecasts range from a low of $146.00 to a high of $190.00. The average price target represents a decline of 8.91% from the last closing price of $176.74.
Analyst Price Targets (3 )
Broker Rating
ICU Medical currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, one is Strong Buy and two are Buy. Strong Buy and Buy respectively account for 25% and 50% of all recommendations. A month ago, Strong Buy made up 25%, while Buy represented 50%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/8/2024 | KeyBanc Capital Markets | Brett Fishbin | Strong Buy | Strong Buy |
8/8/2024 | C.L. King & Associates | Kristen M Stewart | Moderate Buy | Moderate Buy |
6/21/2024 | Needham & Company | Michael Matson | Not Available | Hold |
6/17/2024 | Raymond James | Jayson T Bedford | Hold | Moderate Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 4 |
Average Target Price | $161.00 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 63 of 253 |
Current Quarter EPS Est: | 1.23 |
ICUI FAQs
ICU Medical, Inc. (ICUI) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for ICU Medical, Inc. (ICUI) is $161.00. The current on short-term price targets is based on 2 reports.
The forecasts for ICU Medical, Inc. (ICUI) range from a low of $146 to a high of $190. The average price target represents a decline of $8.91 from the last closing price of $176.74.
The current DOWNSIDE for ICU Medical, Inc. (ICUI) is 8.91%
Based on short-term price targets offered by three analysts, the average price target for ICU Medical comes to $161.00. The forecasts range from a low of $146.00 to a high of $190.00. The average price target represents a decline of 8.91% from the last closing price of $176.74.